SELF-MANAGEMENT STRATEGIES ACROSS CHRONIC DISEASES
Release Date: June 22, 2000
PA NUMBER: PA-00-109
National Institute of Nursing Research
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Child Health and Human Development
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
THIS PA USES THE "MODULAR GRANT" AND "JUST-IN-TIME" CONCEPTS. IT INCLUDES
DETAILED MODIFICATIONS TO STANDARD APPLICATION INSTRUCTIONS THAT MUST BE USED
WHEN PREPARING APPLICATIONS IN RESPONSE TO THIS PA.
PURPOSE
The purpose of this Program Announcement (PA) is to solicit applications to
expand research on established self-management interventions to multiple
chronic diseases across the life-course. Interventions aimed at chronic
disease self-management are numerous and many are well described in the
literature. They are often presented as specific to a particular chronic
disease. This PA encourages applicants to investigate the applicability of
effective self-management interventions to a broader spectrum of chronic
diseases. Chronic disease, for this announcement, is defined as illnesses that
are prolonged, are rarely cured completely, and require self-management
behaviors by affected individuals and/or their caretakers.
HEALTHY PEOPLE 2010
The Public Health Service (PHS) is committed to achieving the health promotion
and disease prevention objectives of "Healthy People 2010," a PHS led national
activity for setting priority areas. This PA, Self-Management Strategies
Across Chronic Diseases, is related to one or more of the priority areas.
Potential applicants may obtain a copy of "Healthy People 2010" at
http://www.health.gov/healthypeople/.
ELIGIBILITY REQUIREMENTS
Applications may be submitted by domestic and foreign, for-profit and non-
profit organizations, public and private, such as universities, colleges,
hospitals, laboratories, units of State and local governments, and eligible
agencies of the Federal government. Racial/ethnic minority individuals,
women, and persons with disabilities are encouraged to apply as principal
investigators.
MECHANISM OF SUPPORT
This PA will use the National Institutes of Health (NIH) Research Project
Grant (R01) award mechanism. Responsibility for the planning, direction, and
execution of the proposed project will be solely that of the applicant. The
total project period for an application submitted in response to this PA may
not exceed 5 years.
Specific application instructions have been modified to reflect "MODULAR
GRANT" and "JUST-IN-TIME" streamlining efforts being examined by the NIH.
Complete and detailed instructions and information on Modular Grant
applications can be found at
http://grants.nih.gov/grants/funding/modular/modular.htm
RESEARCH OBJECTIVES
Self-management behavior, to some degree, has been an expectation for
individuals with a chronic disease for much of the past century. The concept
of self-management and its practice, however, is changing. A more proactive
self-management role is being promoted rather than a health care provider
giving instructions and hoping the patient will adhere to them. Individuals
with a chronic disease are being involved in a more active role. Effective
self-management today includes a broad range of health, lifestyle, and self-
assessment and treatment behaviors by the individual, often with assistance
and support of others. The promotion and maintenance of a healthful and
satisfying life, in the presence of chronic disease, requires individuals to
assume both leadership and partnership roles with health care providers.
The Centers for Disease Control and Prevention (CDC) reports that nearly three
quarters of adults age 65 years and older have one or more chronic illnesses,
and nearly half report two or more. With an aging population, chronic diseases
will increase proportionately. Children and young people who have a chronic
disease can expect to live longer and, therefore, will have a need to manage
their health condition(s) over a longer life span than in the past. With an
increasing life span, older individuals will require more health services
longer for chronic health conditions. Medical care costs for people with
chronic diseases today are more than $400 billion annually, accounting for
more than 60% of total medical care expenditures. Furthermore, the CDC reports
that 7 of every 10 deaths in the U.S. are due to chronic diseases.
The cost of health care for individuals with chronic illnesses does not
typically consider the personal, occupational, and financial costs related to
self-management or disabilities. Nor does it account for the social and
psychological burdens placed on the individual, the family, and society as a
whole by the 90 million Americans with one or more chronic diseases. The
personal and social costs can be affected by improving and supporting healthy
lifestyle and self management behaviors of those affected by chronic disease.
Researchers have developed many effective interventions for chronic disease
self-management. Many of these interventions, however, were developed in one
chronic disease population and not adequately tested in other chronic disease
populations. Studies have shown, for example, that interventions involving
social support, provider-client interactional style, improved self-efficacy,
problem solving or coping skills, and certain follow-up activities have a
positive impact on self-management and health outcomes in specific chronic
diseases. This affects both affected individuals and significant others.
Caregiving knowledge and expertise relevant to diabetes management are often
critical for family members and others assisting dependent children and
elders. Even without a caregiving component, families and significant others
are affected by a member’s chronic condition and its lifestyle and care
requirements.
There is growing interest in the public health arena and across disciplines in
interventions that can be applied across chronic diseases. This initiative to
extend current research to test the effectiveness of self-management
interventions across chronic diseases is a logical next step. Standard
interventions requiring minimal adaptation to a particular disease have the
potential to be more cost effective and less complicated to translate into
practice than those requiring extensive adaptation to each health condition.
Effective self-management interventions for identified chronic diseases and
populations are the expected outcomes of such research. The study of
interventions with a high potential for effectiveness and efficacy across
several chronic diseases may increase the generalizability of findings and
maximize the effectiveness of research and health care dollars.
Scope
This Program Announcement solicits proposals to further test established
interventions for self-management in new populations and across chronic
diseases not previously tested, or adequately tested, for the intervention.
There is a particular interest in extending previously validated interventions
to different chronic disease populations. All age and ethnic groups are of
interest. Examples of approaches include (a) comparing intervention strategies
across two or more groups, each with a different chronic disease or (b)
comparing intervention strategies in a single population with two or more
chronic diseases. Methodology should include common outcome measures for the
intervention across chronic diseases as well as disease-specific outcome
measures.
The following research topics are provided as examples that would extend the
current knowledge base. They are not listed in any priority order and are not
intended to be inclusive or restrictive.
o Investigate intervention strategies that promote chronic illness self-
management across chronic diseases in which they have not been adequately or
previously tested;
o Test intervention strategies that promote self-monitoring, health
behaviors, problem solving, and decision making across chronic diseases;
o Develop standard approaches to promotion and support of self-management
across chronic disease conditions;
o Determine the influence of established approaches to self-management across
chronic diseases (examples: improved self-efficacy, cognitive strategies,
social support, coping skills, provider-client partnership);
o Examine the influence of quality of life, burden of care, culture,
ethnicity, age, family, or socioeconomic status across chronic diseases on
self-management;
o Determine whether age-, gender-, and ethnically-related motivational
factors are associated with improved self-management of chronic diseases in
children.
o Investigate how the multiple co-morbidities and disabilities associated in
the most advanced years affect the types of self-management strategies chosen
as well as the effectiveness of different approaches;
o Test evidence-based clinical guidelines across settings for different age,
ethnic, or socioeconomic groups across chronic diseases; and
o Determine provider roles/approaches and care coordination systems that are
most effective in providing seamless, continuous care that promotes effective
self-management across chronic diseases.
NHLBI: Self-management strategies are applicable to a number of blood
diseases. For example, self monitoring of coagulation status is now possible
with new technologies leading to more precise adjustment of medications. Self-
monitoring also allows home therapy of patients with deep vein thrombosis
utilizing low molecular weight heparin. Patients are increasingly encouraged
to adjust and administer treatments such as iron chelation therapy for those
with secondary iron overload secondary to chronic transfusion, and pain
medication for those with sickle cell disease and recurrent crises. The
patient with hemophilia can now administer clotting factor at home
substantially reducing hospitalization and time lost from school and work.
New communication technologies that link health care providers with patients
also facilitate increasing patient empowerment to monitor and manage their own
chronic blood disease. Innovative proposals to use self-management strategies
to reduce healthcare disparities are especially encouraged.
NIA: NIA is interested in understanding biological, behavioral, and social
factors that affect the aging process and the health and quality of life of
older persons. We are especially interested in the interaction of disease and
care factors with proposed studies explicitly examining the role of aging and
life-course factors in disease onset, progression and/or management. While all
age-related chronic conditions are of interest to NIA, we encourage research
that investigates multiple morbidities common in old age. Self-management
issues associated with Alzheimer’s disease and related disorders are of
particular interest.
NIAMS: The National Institute of Arthritis and Musculoskeletal and Skin
Diseases (NIAMS) is interested in the design, development and testing of new
and improved self-management programs for rheumatic and related diseases such
as arthritis, lupus, scleroderma and fibromyalgia, disorders of the
musculoskeletal system, and diseases of muscle, bone, and skin. Within these
areas, the Institute encourages the development of self-management programs
that target women, children and disproportionally affected patient populations
NIMH: The NIMH encourages applications that explicitly and centrally explore
the role of mental disorders/symptoms/related disability. We are particularly
interested in studies on modifiable risk and protective processes and the
development and initial testing of new interventions. The interventions may
be pharmacologic, behavioral, or psychosocial.
NINDS: The National Institute of Neurological Disorders and Stroke (NINDS) is
interested in the development and evaluation of interventions for initiation
and maintenance of self-management activities applicable to patients with
chronic neurological disorders (e.g., epilepsy) and stroke. Self-management
interventions for patients with neurological disorders and stroke require
special adaptation to reflect psychiatric co-morbidities and cognitive
deficits in these patients. Interventions for stroke patients need to address
multiple self-management activities, including drug regimens and lifestyle
changes.
INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS
It is the policy of the NIH that women and members of minority groups and
their subpopulations must be included in all NIH supported biomedical and
behavioral research projects involving human subjects, unless a clear and
compelling rationale and justification are provided that inclusion is
inappropriate with respect to the health of the subjects or the purpose of the
research. This policy results from the NIH Revitalization Act of 1993
(Section 492B of Public Law 103-43).
All investigators proposing research involving human subjects should read the
"NIH Guidelines For Inclusion of Women and Minorities as Subjects in Clinical
Research," which have been published in the Federal Register of March 28, 1994
(FR 59 14508-14513) and in the NIH Guide for Grants and Contracts, Vol. 23,
No. 11, March 18, 1994 and is available on the web at the following URL
address: http://grants.nih.gov/grants/guide/notice-files/not94-100.html
INCLUSION OF CHILDREN AS PARTICIPANTS IN RESEARCH INVOLVING HUMAN SUBJECTS
It is the policy of NIH that children (i.e., individuals under the age of 21)
must be included in all human subjects research, conducted or supported by the
NIH, unless there are scientific and ethical reasons not to include them.
This policy applies to all initial (Type 1) applications submitted for receipt
dates after October 1, 1998.
All investigators proposing research involving human subjects should read the
"NIH Policy and Guidelines on the Inclusion of Children as Participants in
Research Involving Human Subjects" that was published in the NIH Guide for
Grants and Contracts, March 6, 1998, and is available at the following URL
address: http://grants.nih.gov/grants/guide/notice-files/not98-024.html
Investigators also may obtain copies of these policies from the program staff
listed under INQUIRIES. Program staff may also provide additional relevant
information concerning the policy.
NOTE FOR APPLICATIONS FOCUSED ON AGING RESEARCH
Applications received in response to this program announcement are expected to
focus on scientific issues related to aging and to aging-related aspects of
disease. In describing the plan to recruit human subjects, investigators may
cite a focus on aging or on aging-related aspects of disease as the
justification for why children will be excluded. In this regard, applicants
may use Justification 1, the research topic to be studied is irrelevant to
children, from the policy announcement.
URLS IN NIH GRANT APPLICATIONS OR APPENDICES
All applications and proposals for NIH funding must be self-contained within
specified page limitations. Unless otherwise specified in an NIH solicitation,
internet addresses (URLs) should not be used to provide information necessary
to the review because reviewers are under no obligation to view the Internet
sites. Reviewers are cautioned that their anonymity may be compromised when
they directly access an Internet site.
APPLICATION PROCEDURES
Applications are to be submitted on the grant application form PHS 398 (rev.
4/98) and will be accepted at the standard application deadlines as indicated
in the application kit. Application kits are available at most institutional
offices of sponsored research and may be obtained from the Division of
Extramural Outreach and Information Resources, National Institutes of Health,
6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892-7910, telephone 301/710-0267, email: GrantsInfo@nih.gov.
Applicants planning to submit an investigator-initiated new (type 1),
competing continuation (type 2), competing supplement, or any amended/revised
version of the preceding grant application types requesting $500,000 or more
in direct costs for any year are advised that he or she must contact the
Institute or Center (IC) program staff before submitting the application,
i.e., as plans for the study are being developed. Furthermore, the
application must obtain agreement from the IC staff that the IC will accept
the application for consideration for award. Finally, the applicant must
identify, in a cover letter sent with the application, the staff member and
Institute or Center who agreed to accept assignment of the application.
This policy requires an applicant to obtain agreement for acceptance of both
any such application and any such subsequent amendment. Refer to the NIH
Guide for Grants and Contracts, March 20, 1998 at
http://grants.nih.gov/grants/guide/notice-files/not98-030.html
The modular grant concept establishes specific modules in which direct costs
may be requested as well as a maximum level for requested budgets. Only
limited budgetary information is required under this approach. The
just-in-time concept allows applicants to submit certain information only when
there is a possibility for an award. It is anticipated that these changes will
reduce the administrative burden for the applicants, reviewers and Institute
staff. The research grant application form PHS 398 (rev. 4/98) is to be used
in applying for these grants, with the modifications noted below.
SPECIFIC INSTRUCTIONS FOR MODULAR GRANT APPLICATIONS
BUDGET INSTRUCTIONS
Modular Grant applications will request direct costs in $25,000 modules, up to
a total direct cost request of $250,000 per year. (Applications that request
more than $250,000 direct costs in any year must follow the traditional PHS
398 application instructions.) The total direct costs must be requested in
accordance with the program guidelines and the modifications made to the
standard PHS 398 application instructions described below:
PHS 398
o FACE PAGE: Items 7a and 7b should be completed, indicating Direct Costs (in
$25,000 increments up to a maximum of $250,000) and Total Costs [Modular Total
Direct plus Facilities and Administrative (F&A) costs] for the initial budget
period Items 8a and 8b should be completed indicating the Direct and Total
Costs for the entire proposed period of support.
o DETAILED BUDGET FOR THE INITIAL BUDGET PERIOD - Do not complete Form Page 4
of the PHS 398. It is not required and will not be accepted with the
application.
o BUDGET FOR THE ENTIRE PROPOSED PERIOD OF SUPPORT - Do not complete the
categorical budget table on Form Page 5 of the PHS 398. It is not required and
will not be accepted with the application.
o NARRATIVE BUDGET JUSTIFICATION - Prepare a Modular Grant Budget Narrative
page. (See http://grants.nih.gov/grants/funding/modular/modular.htm for sample
pages.) At the top of the page, enter the total direct costs requested for
each year. This is not a Form page.
o Under Personnel, List key project personnel, including their names, percent
of effort, and roles on the project. No individual salary information should
be provided. However, the applicant should use the NIH appropriation language
salary cap and the NIH policy for graduate student compensation in developing
the budget request.
For Consortium/Contractual costs, provide an estimate of total costs (direct
plus facilities and administrative) for each year, each rounded to the nearest
$1,000. List the individuals/organizations with whom consortium or contractual
arrangements have been made, the percent effort of key personnel, and the role
on the project. Indicate whether the collaborating institution is foreign or
domestic. The total cost for a consortium/contractual arrangement is included
in the overall requested modular direct cost amount. Include the Letter of
Intent to establish a consortium.
Provide an additional narrative budget justification for any variation in the
number of modules requested.
o BIOGRAPHICAL SKETCH - The Biographical Sketch provides information used by
reviewers in the assessment of each individual's qualifications for a specific
role in the proposed project, as well as to evaluate the overall
qualifications of the research team. A biographical sketch is required for all
key personnel, following the instructions below. No more than three pages may
be used for each person. A sample biographical sketch may be viewed at:
http://grants.nih.gov/grants/funding/modular/modular.htm
- Complete the educational block at the top of the form page;
- List position(s) and any honors;
- Provide information, including overall goals and responsibilities, on
research projects ongoing or completed during the last three years.
- List selected peer-reviewed publications, with full citations;
o CHECKLIST - This page should be completed and submitted with the
application. If the F&A rate agreement has been established, indicate the type
of agreement and the date. All appropriate exclusions must be applied in the
calculation of the F&A costs for the initial budget period and all future
budget years.
o The applicant should provide the name and phone number of the individual to
contact concerning fiscal and administrative issues if additional information
is necessary following the initial review.
The title and number of the program announcement must be typed on line 2 of
the face page of the application form and the YES box must be marked.
Submit a signed, typewritten original of the application, including the
Checklist, and five signed photocopies in one package to:
CENTER FOR SCIENTIFIC REVIEW
NATIONAL INSTITUTES OF HEALTH
6701 ROCKLEDGE DRIVE, ROOM 1040, MSC 7710
BETHESDA, MD 20892-7710
BETHESDA, MD 20817 (for express/courier service)
REVIEW CONSIDERATIONS
Applications will be assigned on the basis of established PHS referral
guidelines. Applications will be evaluated for scientific and technical merit
by an appropriate scientific review group convened in accordance with the
standard NIH peer review procedures. As part of the initial merit review, all
applications will receive a written critique and undergo a process in which
only those applications deemed to have the highest scientific merit, generally
the top half of applications under review, will be discussed, assigned a
priority score, and receive a second level review by the appropriate National
Advisory Council.
Review Criteria
The goals of NIH-supported research are to advance our understanding of
biological systems, improve the control of disease, and enhance health. In
the written comments reviewers will be asked to discuss the following aspects
of the application in order to judge the likelihood that the proposed research
will have a substantial impact on the pursuit of these goals. Each of these
criteria will be addressed and considered in assigning the overall score,
weighting them as appropriate for each application. Note that the application
does not need to be strong in all categories to be judged likely to have major
scientific impact and thus deserve a high priority score. For example, an
investigator may propose to carry out important work that by its nature is not
innovative but is essential to move a field forward.
(1) Significance: Does this study address an important problem? If the aims
of the application are achieved, how will scientific knowledge be advanced?
What will be the effect of these studies on the concepts or methods that drive
this field?
(2) Approach: Are the conceptual framework, design, methods, and analyses
adequately developed, well-integrated, and appropriate to the aims of the
project? Does the applicant acknowledge potential problem areas and consider
alternative tactics?
(3) Innovation: Does the project employ novel concepts, approaches or method?
Are the aims original and innovative? Does the project challenge existing
paradigms or develop new methodologies or technologies?
(4) Investigator: Is the investigator appropriately trained and well suited
to carry out this work? Is the work proposed appropriate to the experience
level of the principal investigator and other researchers (if any)?
(5) Environment: Does the scientific environment in which the work will be
done contribute to the probability of success? Do the proposed experiments
take advantage of unique features of the scientific environment or employ
useful collaborative arrangements? Is there evidence of institutional
support?
In addition to the above criteria, in accordance with NIH policy, all
applications will also be reviewed with respect to the following:
o The adequacy of plans to include both genders, minorities and their
subgroups, and children as appropriate for the scientific goals of the
research. Plans for the recruitment and retention of subjects will also be
evaluated.
o The reasonableness of the proposed budget and duration in relation to the
proposed research
o The adequacy of the proposed protection for humans, animals or the
environment, to the extent they may be adversely affected by the project
proposed in the application.
Additional scientific/technical merit criteria specific to the objectives of
the PA and the mechanism used must be included if they are to be used in the
review.
AWARD CRITERIA
Applications will compete for available funds with all other recommended
applications. The following will be considered in making funding decisions:
Quality of the proposed project as determined by peer review, availability of
funds, and program priority.
INQUIRIES
Inquiries are encouraged. The opportunity to clarify any issues or questions
from potential applicants is welcome.
Direct inquiries regarding GENERAL ISSUES to:
Dr. Nell Armstrong
Division of Extramural Activities
National Institute of Nursing Research
Building 45, Room Number 3AN12, MSC 6300
Bethesda, MD 20892-6300
Telephone: (301) 594-5973
FAX: (301) 480-8260
Email: nell_Armstrong@nih.gov
Direct inquiries regarding specific PROGRAMMATIC ISSUES to the staff of the
appropriate Institute/Center:
Dr. Nell Armstrong
Division of Extramural Activities
National Institute of Nursing Research
Building 45, Room 3AN12, MSC 6300
Bethesda, MD 20892-6300
Telephone: (301) 594-5973
FAX: (301) 480-8260
Email: nell_Armstrong@nih.gov
Dr. Carol H. Letendre, Ph.D.
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, Room 10162, MSC 7950
Bethesda, MD 20892-7950
Telephone: 301-435-0080
FAX: 301-480-0867
Email: letendrc@nhlbi.nih.gov
Marcia G. Ory, Ph.D., M.P.H.
Behavioral and Social Research Program
National Institute on Aging
7201 Wisconsin Avenue, Room 533 MSC 9025
Bethesda, MD 20892-9205
Telephone: 301-402-4156
FAX: 301-402-0051
Email: Marcia_Ory@NIH.GOV
Susana Serrate-Sztein, M.D.
Rheumatic Diseases Branch
National Institute of Arthritis and Musculoskeletal and Skin Diseases
45 Center Drive, Natcher Bldg. Rm. 5A25
Bethesda MD 20892-6500
Telephone: (3101) 594-5032
FAX (301) 480-4543
Email: szteins@mail.nih.gov
Lynne M. Haverkos, M.D., MPH
Child Development and Behavior Branch
National Institute of Child Health and Human Development
6100 Executive Boulevard, Room 4B05B, MSC 7510
Bethesda, MD 20892-7510
Telephone: (301) 435-6881
FAX: (301) 480-7773
Email: lh179r@nih.gov
Paul L Kimmel, MD
Division of Kidney Urologic and Hematologic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
6707 Democracy Boulevard, Room 607, MSC 5458
Bethesda, MD 20892-5458
Telephone: 301-594-7717
FAX: 301-480-3510
Email: KimmelP@extra.niddk.nih.gov
Peter Muehrer, Ph.D.
Division of Mental Disorders, Behavioral Research, and AIDS
National Institute of Mental Health
6001 Executive Boulevard, Room 6189, MSC 9615
Bethesda, MD 20892-9615
Telephone: 301-443-4708
FAX: 301-480-4415
Email: pmuehrer@nih.gov
Barbara Radziszewska, PhD, MPH
Clinical Research Project Manager
National Institute of Neurological Disorders and Stroke
6001 Executive Boulevard, Room 2215, MSC 9520
Bethesda, MD 20892-9520
Rockville, MD 20852 (for courier/express service)
Telephone: (301) 496-2076
FAX: (301) 480-1080
Email: br94h@nih.gov
Direct inquiries regarding FISCAL MATTERS to:
Mr. Robert Tarwater
Office of Grants and Contracts Management
National Institute of Nursing Research
Building 45, Room Number 3AN12, MSC 6300
Bethesda, MD 20892-6300
Telephone: (301) 594-2807
FAX: (301) 480-8260
Email: Robert_tarwater@nih.gov
Ms. Suzanne White
Division of Extramural Affairs
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, Room 7174, MSC 7926
Bethesda, MD 20892-7926
Telephone: 301-435-0166
Fax: 301-480-3310
Email: whites@nhlbi.nih.gov
Mr. David Reiter
Grants Management Office
National Institute on Aging
Gateway Building, Room 2N212
Bethesda, MD 20892
Telephone: 30l-496-1472
FAX: 301-402-3672
Email: David_Reiter@NIH.GOV
Ms. Melinda Nelson
Grants Management Officer
National Institute of Arthritis and Musculoskeletal and Skin Diseases
45 Center Drive, Natcher Bldg. Rm. 5A49F
Bethesda, MD 20892-6500
Telephone: (3101) 594-3505
FAX (301) 480-4543
Email: nelsonm@mail.nih.gov
E. Douglas Shawver
Grants Management Branch
National Institute of Child Health and Human Development
6100 Executive Boulevard, Room 8A17, MSC 7510
Bethesda, MD 20892-7510
Telephone: (301) 435-6999
FAX: (301) 402-0915
Email: shawverd@exchange.nih.gov
Ms. Cheryl Chick
Grants Management Specialist
National Institute of Diabetes and Digestive and Kidney Diseases
6707 Democracy Boulevard, Room 606
Bethesda, MD 20892-5456
Telephone: 301-594-8825
FAX: 301-480-3504
Email: chickc@extra.niddk.nih.gov
Ms. Diana S. Trunnell
Grants Management Branch
National Institute of Mental Health
6001 Executive Boulevard, Room 6115, MSC 9605
Bethesda, MD 20892-9605
Telephone: (301) 443-2805
FAX: (301) 443-6885
Email: Diana_Trunnell@nih.gov
Gladys Melendez-Bohler, M.S.
Grants Management Branch
National Institute of Neurological Disorders and Stroke
6001 Executive Boulevard, Suite 3262
Rockville, MD 20892
Telephone: 301-496-3929
FAX: 301-402-0219
Email: gb13y@nih.gov
AUTHORITY AND REGULATIONS
This program is described in the Catalog of Federal Domestic Assistance Nos.
93.361 (NINR); 93.839 (NHLBI); 93.866 (NIA); 93.846 (NIAMS); 93.865 (NICHD);
93.849 (NIDDK); 93.242 (NIMH); and 93.853 (NINDS). Awards are made under
authorization of sections 301 and 405 of the Public Health Service Act as
amended (42 USC 241 and 284) and administered under NIH grants policies and
Federal Regulations 42 CFR 52 and 45 CFR Parts 74 and 92. This program is not
subject to the intergovernmental review requirements of Executive Order 12372
or Health Systems Agency review.
The PHS strongly encourages all grant and contract recipients to provide a
smoke-free workplace and promote the non-use of all tobacco products. In
addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking
in certain facilities (or in some cases, and portion of a facility) in which
regular or routine education, library, day care, health care or early
childhood development services are provided to children. This is consistent
with the PHS mission to protect and advance the physical and mental health of
the American people.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
|
|
|
Department of Health and Human Services (HHS)
|
|
|
|
NIH... Turning Discovery Into Health®
|